Clinical Trial Update: Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in locally advanced esophageal cancer evaluated irinotecan, cisplatin, and bevacizumab with radiation therapy and surgery. Results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-12